Buradasınız

Anasayfa » Content

FACTORS ASSOCIATED WITH ADHERENCE TO ANTIHYPERTENSIVE TREATMENT AMONG HYPERTENSIVE PERSONS IN A URBAN SLUM AREA OF HYDERABAD

Journal Name:

  • Indian Journal of Basic & Applied Medical Research

Publication Year:

  • 2014

Key Words:

Author Name
Abstract (2. Language): 
Background: Hypertension is an overwhelming global challenge with high morbidity and mortality rates. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. Objective: To assess adherence to antihypertensive therapy and and to assess associated factors for adherence among HTN patients. Method: A cross-sectional study was conducted on 220 hypertensive patients aged 20years and above residing in Urban Slum area of Hyderabad. The data was collected using a pretested structured questionnaire consisting of 3 sections: Section IParticipants general information, Section II-Diagnosis and treatment details of hypertension, and Section III -The 4-item Morisky questionnaire. Results: A total of 220 individuals aged 20 years and above on anti-hypertensive treatment for more than 6 months were interviewed. Better adherence and a statically significant association were found in patient above 60 years of age (67.2%), married people (84.7%), non smokers (74.8%) and non tobacco users (68.9%) and among people consuming 1 tablet a day (67.7%).
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-factors-associated-adherence-antihypertensive-treatment-among-hypertensive-persons-urban-slum-area-hyderabad.pdf
  • 1
471
477
  • English

REFERENCES

References: 

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis
of worldwide data. Lancet 2005, 365 (9455):217–223.
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr: Jones DW, Materson BJ, Oparil S,
Wright JT Jr, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. Hypertension 2003, 42(6):1206–1252.
3. Primatesta P, Poulter NR: Improvement in hypertension management in England: results from the Health
Survey for England 2003. J Hypertens 2006, 24(6):1187–1192.
4. Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, Ishaq M, Ambreen A, Ahmad U:
Factors associated with adherence to antihypertensive treatment in Pakistan. PLoS One 2007, 2(3):e280.
5. Kumar N, Unnikrishnan B, Thapar R, Mithra P, Kulkarni V, Holla R, Bhagawan D, Mehta I. Factors Associated
With Adherence To Antihypertensive Treatment Among Patients Attending A Tertiary Care Hospital In
Mangalore, South India. IJCRR. (2014), [Cited January 30, 2015]; 6(10): 77-85.
6. Ong KL, Cheung BMY, Man YB, Lau CP, Lam KSL: Prevalence, Awareness, Treatment, and Control of
Hypertension Among United States Adults 1999–2004. Hypertension 2006, 49:69–75.
7. Balkrishnan R: The importance of medication adherence in improving chronic-disease related outcomes: what
we need to further know. Med Care 2005, 43(6):517–520.
8. K Park. Park’s Textbook of Preventive and Social Medicine, 21st ed. Jabalpur: Bhanot Publishers; 2011. Pg no
345.
9. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of
medication adherence. Med Care 1986, 24(1):67–74.
476
Indian Journal of Basic and Applied Medical Research; December 2014: Vol.-4, Issue- 1, P. 471-477
472
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
10. Inkster ME, Donnan PT, MacDonald TM, Sullivan FM, Fahey T: Adherence to antihypertensive medication
and association with patient and practice factors. J Hum Hypertens 2006, 20(4):295–297
11. Bairwa M, Rajput M, Sachdeva S. Modified kuppuswamy's socioeconomic scale: social researcher should
include updated income criteria, 2012. Indian J Community Med 2013;38:185-6
12. Rybacki JJ. Improving cardiovascular health in postmenopausal women by addressing medication adherence
issues. Journal of the American Pharmaceutical Association, 2002, 42:63-71.
13. Dunbar-Jacob J et al.Adherence in chronic disease. Annual Review of Nursing Research, 2000, 18:48-90.
14. WHO 2003.Adherence to long-term therapies-Evidence for action. Available at
URL:http://whqlibdoc.who.int/publications/2003/9241545992.pdf. Accessed on: 24/01/2015.
15. Abere Dessie Ambaw, Getahun Asres Alemie, Solomon Meseret W/Yohannes, Mengesha J B. Adherence to
antihypertensive treatment and associated factors among patients on follow up at University of Gondar
Hospital, Northwest Ethiopia. BMC Public Health,2012, 12:282 Available at
http://www.biomedcentral.com/1471-2458/12/282.
16. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of
medication adherence. Med Care 1986, 24(1):67–74.
17. van der Sande MA, Milligan PJ, Nyan OA, Rowley JT, Banya WA, Ceesay SM, Dolmans WM, Thien T,
McAdam KP, Walraven GE: Blood pressure patterns and cardiovascular risk factors in rural and urban gambian
communities. J Hum Hypertens 2000, 14(8):489–496.
18. Kumar N, Unnikrishnan B, Thapar R, Mithra P, Kulkarni V, Holla R, Bhagawan D, Mehta I. Factors Associated
With Adherence To Antihypertensive Treatment Among Patients Attending A Tertiary Care Hospital In
Mangalore, South India. IJCRR. (2014), [cited January 30, 2015]; 6(10): 77-85.
19. Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to
antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS
One 2013; 8 (4): e62775. doi:10.1371/journal.pone.0062775
20. Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM et al.Factors associated with
adherence to anti-hypertensive treatment in Pakistan. PLoS One. 2007 Mar 14;2 (3):e280.
21. Inkster ME, Donnan PT, MacDonald TM, Sullivan FM, Fahey T: Adherence to antihypertensive medication
and association with patient and practice factors. J Hum Hypertens 2006, 20(4):295–297.

Thank you for copying data from http://www.arastirmax.com